PsyBio Therapeutics Valuation
| PSYBF Stock | USD 0.0001 0.00 0.00% |
PsyBio Therapeutics seems to be undervalued based on Macroaxis valuation methodology. Our model determines the value of PsyBio Therapeutics Corp from analyzing the company fundamentals such as Return On Equity of -3.1, gross profit of (1.56 M), and Shares Outstanding of 80.85 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that PsyBio Therapeutics' price fluctuation is out of control at this time. Calculation of the real value of PsyBio Therapeutics Corp is based on 3 months time horizon. Increasing PsyBio Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PsyBio pink sheet is determined by what a typical buyer is willing to pay for full or partial control of PsyBio Therapeutics Corp. Since PsyBio Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PsyBio Pink Sheet. However, PsyBio Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 0.002713 | Hype 1.07E-4 |
The real value of PsyBio Pink Sheet, also known as its intrinsic value, is the underlying worth of PsyBio Therapeutics Corp Company, which is reflected in its stock price. It is based on PsyBio Therapeutics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of PsyBio Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of PsyBio Therapeutics Corp helps investors to forecast how PsyBio pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PsyBio Therapeutics more accurately as focusing exclusively on PsyBio Therapeutics' fundamentals will not take into account other important factors: PsyBio Therapeutics Total Value Analysis
PsyBio Therapeutics Corp is at this time forecasted to have takeover price of 3.69 M with market capitalization of 4.94 M, debt of 207.81 K, and cash on hands of 911.83 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the PsyBio Therapeutics fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.69 M | 4.94 M | 207.81 K | 911.83 K |
PsyBio Therapeutics Asset Utilization
One of the ways to look at asset utilization of PsyBio is to check how much profit was generated for every dollar of assets it reports. PsyBio Therapeutics holds a negative application of assets of -0.98 pct., losing $0.009829 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of PsyBio Therapeutics Corp shows how discouraging it operates for each dollar spent on its assets.PsyBio Therapeutics Ownership Allocation
PsyBio Therapeutics owns a total of 80.85 Million outstanding shares. PsyBio Therapeutics has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.PsyBio Therapeutics Profitability Analysis
Net Loss for the year was (11.02 M) with loss before overhead, payroll, taxes, and interest of (1.56 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates PsyBio Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in PsyBio Therapeutics and how it compares across the competition.
About PsyBio Therapeutics Valuation
The pink sheet valuation mechanism determines PsyBio Therapeutics' current worth on a weekly basis. Our valuation model uses a comparative analysis of PsyBio Therapeutics. We calculate exposure to PsyBio Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PsyBio Therapeutics's related companies.PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. Psybio Therapeautics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
8 Steps to conduct PsyBio Therapeutics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates PsyBio Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct PsyBio Therapeutics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain PsyBio Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine PsyBio Therapeutics' revenue streams: Identify PsyBio Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research PsyBio Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish PsyBio Therapeutics' growth potential: Evaluate PsyBio Therapeutics' management, business model, and growth potential.
- Determine PsyBio Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate PsyBio Therapeutics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
PsyBio Therapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as PsyBio Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 113 M | |
| Retained Earnings | -16.9 M | |
| Shares Float | 65 M |
Complementary Tools for PsyBio Pink Sheet analysis
When running PsyBio Therapeutics' price analysis, check to measure PsyBio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PsyBio Therapeutics is operating at the current time. Most of PsyBio Therapeutics' value examination focuses on studying past and present price action to predict the probability of PsyBio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PsyBio Therapeutics' price. Additionally, you may evaluate how the addition of PsyBio Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |